Industry Research Reports
Home > Reports > Medical Devices & Consumables > Global MRI Contrast Agents Market Outlook, In‑Depth Analysis & Forecast to 2031
Global MRI Contrast Agents Market Outlook, In‑Depth Analysis & Forecast to 2031
Industry: Medical Devices & Consumables
Published Date: 2025-07-31
Pages: 145 Pages
Report ld: 4808862
Request Sample
Customized Report
- Description
- Table of Contents
- Table of Figures
- Related Reports
PDF Download
- Description
- Table of Contents
- Table of Figures
- Related Reports
- PDF Download
MRI Contrast Agents Market Size(US$)
CAGR 2025-2031
5.9%
Market Size,2031
USD 2,339
Million
Market Snapshot
Market Size in 2025 (Value)
US$ 1,661 million
Market Forecast in 2031(Value)
US$ 2,339 million
CAGR
5.9%
Years Considered
2020-2031
Base Year
2025
Forecast Period
2025-2031
Source: Secondary research, interviews with experts, and QYResearch analysis
The global MRI Contrast Agents market is projected to grow from US$ 1578 million in 2024 to US$ 2339 million by 2031, at a CAGR of 5.9% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
MRI contrast agents are contrast agents used to improve the visibility of internal body structures in magnetic resonance imaging (MRI). The most commonly used compounds for contrast enhancement are gadolinium-based. Such MRI contrast agents shorten the relaxation times of nuclei within body tissues following oral or intravenous administration.
Global key MRI contrast agents core players include Bayer, Guerbet Group and Bracco Imaging etc. The top 3 companies hold a share about 82%. Asia-Pacific is the largest market with a share about 35%, followed by North America and Europe.
In terms of product, gadoterate meglumine product is the largest segment with a share about 27%. And in terms of applications, the largest application is hospital with a share about 84%.
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global MRI Contrast Agents market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
By Company
- Bayer
- Guerbet Group
- Bracco Imaging
- GE Healthcare
- BeiLu Pharma
- Hengrui Medicine
Consumption by Region
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia-Pacific
- Europe
- Germany
- France
- U.K.
- Italy
- Netherlands
- Nordic Countries
- Rest of Europe
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
Segment by Type
- Gadobutrol
- Gadoterate Meglumine
- Gadobenate Dimeglumine
- Gadopentetate Dimeglumine
- Gadoteridol
- Gadodiamine
- Others
Segment by Application
- Hospitals
- Clinics
CHAPTER OUTLINE
Chapter 1: Defines the MRI Contrast Agents study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
Market entry risks/opportunities by region
We identify regional market threats and growth prospects to guide your overseas layout.
Product mix optimization based on local practices
We adjust product portfolios in line with local consumption habits.
Competitor tactics in fragmented vs. consolidated markets
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
Full Research Coverage
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
19 Years Industry Expertise
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
24/7 Fast Report Delivery
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
Localized Strategic Analysis
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
Market entry risks/opportunities by region
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
Market entry risks/opportunities by region
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to MRI Contrast Agents: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global MRI Contrast Agents Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Gadobutrol
1.2.3 Gadoterate Meglumine
1.2.4 Gadobenate Dimeglumine
1.2.5 Gadopentetate Dimeglumine
1.2.6 Gadoteridol
1.2.7 Gadodiamine
1.2.8 Others
1.3 Market Segmentation by Application
1.3.1 Global MRI Contrast Agents Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Clinics
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global MRI Contrast Agents Revenue Estimates and Forecasts 2020-2031
2.2 Global MRI Contrast Agents Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global MRI Contrast Agents Sales Estimates and Forecasts 2020-2031
2.4 Global MRI Contrast Agents Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global MRI Contrast Agents Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global MRI Contrast Agents Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 Gadobutrol Market Size by Manufacturers
3.5.2 Gadoterate Meglumine Market Size by Manufacturers
3.5.3 Gadobenate Dimeglumine Market Size by Manufacturers
3.5.4 Gadopentetate Dimeglumine Market Size by Manufacturers
3.5.5 Gadoteridol Market Size by Manufacturers
3.5.6 Gadodiamine Market Size by Manufacturers
3.5.7 Others Market Size by Manufacturers
3.6 Global MRI Contrast Agents Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global MRI Contrast Agents Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global MRI Contrast Agents Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global MRI Contrast Agents Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global MRI Contrast Agents Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America MRI Contrast Agents Sales and Revenue by Type (2020-2031)
6.4 North America MRI Contrast Agents Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America MRI Contrast Agents Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe MRI Contrast Agents Sales and Revenue by Type (2020-2031)
7.4 Europe MRI Contrast Agents Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe MRI Contrast Agents Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific MRI Contrast Agents Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific MRI Contrast Agents Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific MRI Contrast Agents Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America MRI Contrast Agents Sales and Revenue by Type (2020-2031)
9.4 Central and South America MRI Contrast Agents Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America MRI Contrast Agents Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa MRI Contrast Agents Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa MRI Contrast Agents Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa MRI Contrast Agents Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 Bayer
11.1.1 Bayer Corporation Information
11.1.2 Bayer Business Overview
11.1.3 Bayer MRI Contrast Agents Product Models, Descriptions and Specifications
11.1.4 Bayer MRI Contrast Agents Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 Bayer MRI Contrast Agents Sales by Product in 2024
11.1.6 Bayer MRI Contrast Agents Sales by Application in 2024
11.1.7 Bayer MRI Contrast Agents Sales by Geographic Area in 2024
11.1.8 Bayer MRI Contrast Agents SWOT Analysis
11.1.9 Bayer Recent Developments
11.2 Guerbet Group
11.2.1 Guerbet Group Corporation Information
11.2.2 Guerbet Group Business Overview
11.2.3 Guerbet Group MRI Contrast Agents Product Models, Descriptions and Specifications
11.2.4 Guerbet Group MRI Contrast Agents Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 Guerbet Group MRI Contrast Agents Sales by Product in 2024
11.2.6 Guerbet Group MRI Contrast Agents Sales by Application in 2024
11.2.7 Guerbet Group MRI Contrast Agents Sales by Geographic Area in 2024
11.2.8 Guerbet Group MRI Contrast Agents SWOT Analysis
11.2.9 Guerbet Group Recent Developments
11.3 Bracco Imaging
11.3.1 Bracco Imaging Corporation Information
11.3.2 Bracco Imaging Business Overview
11.3.3 Bracco Imaging MRI Contrast Agents Product Models, Descriptions and Specifications
11.3.4 Bracco Imaging MRI Contrast Agents Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 Bracco Imaging MRI Contrast Agents Sales by Product in 2024
11.3.6 Bracco Imaging MRI Contrast Agents Sales by Application in 2024
11.3.7 Bracco Imaging MRI Contrast Agents Sales by Geographic Area in 2024
11.3.8 Bracco Imaging MRI Contrast Agents SWOT Analysis
11.3.9 Bracco Imaging Recent Developments
11.4 GE Healthcare
11.4.1 GE Healthcare Corporation Information
11.4.2 GE Healthcare Business Overview
11.4.3 GE Healthcare MRI Contrast Agents Product Models, Descriptions and Specifications
11.4.4 GE Healthcare MRI Contrast Agents Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 GE Healthcare MRI Contrast Agents Sales by Product in 2024
11.4.6 GE Healthcare MRI Contrast Agents Sales by Application in 2024
11.4.7 GE Healthcare MRI Contrast Agents Sales by Geographic Area in 2024
11.4.8 GE Healthcare MRI Contrast Agents SWOT Analysis
11.4.9 GE Healthcare Recent Developments
11.5 BeiLu Pharma
11.5.1 BeiLu Pharma Corporation Information
11.5.2 BeiLu Pharma Business Overview
11.5.3 BeiLu Pharma MRI Contrast Agents Product Models, Descriptions and Specifications
11.5.4 BeiLu Pharma MRI Contrast Agents Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 BeiLu Pharma MRI Contrast Agents Sales by Product in 2024
11.5.6 BeiLu Pharma MRI Contrast Agents Sales by Application in 2024
11.5.7 BeiLu Pharma MRI Contrast Agents Sales by Geographic Area in 2024
11.5.8 BeiLu Pharma MRI Contrast Agents SWOT Analysis
11.5.9 BeiLu Pharma Recent Developments
11.6 Hengrui Medicine
11.6.1 Hengrui Medicine Corporation Information
11.6.2 Hengrui Medicine Business Overview
11.6.3 Hengrui Medicine MRI Contrast Agents Product Models, Descriptions and Specifications
11.6.4 Hengrui Medicine MRI Contrast Agents Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Hengrui Medicine Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 MRI Contrast Agents Industry Chain
12.2 MRI Contrast Agents Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 MRI Contrast Agents Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 MRI Contrast Agents Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 MRI Contrast Agents Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global MRI Contrast Agents Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
TABLE OF FIGURES
List of Tables
Table 1. Global MRI Contrast Agents Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Table 2. Global MRI Contrast Agents Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Table 3. Global MRI Contrast Agents Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 4. Global MRI Contrast Agents Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global MRI Contrast Agents Revenue by Region (2026-2031) & (US$ Million)
Table 6. Global MRI Contrast Agents Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (Liter)
Table 7. Global MRI Contrast Agents Sales by Region (2020-2025) & (Liter)
Table 8. Global MRI Contrast Agents Sales by Region (2026-2031) & (Liter)
Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 10. Global MRI Contrast Agents Sales by Manufacturers (2020-2025) & (Liter)
Table 11. Global MRI Contrast Agents Sales Share by Manufacturers (2020-2025)
Table 12. Global MRI Contrast Agents Revenue by Manufacturers (2020-2025) & (US$ Million)
Table 13. Global MRI Contrast Agents Revenue Market Share by Manufacturers (2020-2025)
Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
Table 15. Global MRI Contrast Agents by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in MRI Contrast Agents as of 2024)
Table 16. Global MRI Contrast Agents Average Gross Margin (%) by Manufacturer (2020 VS 2024)
Table 17. Global MRI Contrast Agents Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/mL)
Table 18. Key Manufacturers MRI Contrast Agents Manufacturing Base and Headquarters
Table 19. Global MRI Contrast Agents Market Concentration Ratio (CR5 and HHI)
Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
Table 22. Global MRI Contrast Agents Sales by Type (2020-2025) & (Liter)
Table 23. Global MRI Contrast Agents Sales by Type (2026-2031) & (Liter)
Table 24. Global MRI Contrast Agents Revenue by Type (2020-2025) & (US$ Million)
Table 25. Global MRI Contrast Agents Revenue by Type (2026-2031) & (US$ Million)
Table 26. Global MRI Contrast Agents ASP by Type (2020-2031) & (US$/mL)
Table 27. Technical Specifications by Key Product Type
Table 28. Global MRI Contrast Agents Sales by Application (2020-2025) & (Liter)
Table 29. Global MRI Contrast Agents Sales by Application (2026-2031) & (Liter)
Table 30. MRI Contrast Agents High-Growth Sectors Demand CAGR (2024-2031)
Table 31. Global MRI Contrast Agents Revenue by Application (2020-2025) & (US$ Million)
Table 32. Global MRI Contrast Agents Revenue by Application (2026-2031) & (US$ Million)
Table 33. Global MRI Contrast Agents ASP by Application (2020-2031) & (US$/mL)
Table 34. Top Customers by Region
Table 35. Top Customers by Application
Table 36. North America MRI Contrast Agents Growth Accelerators and Market Barriers
Table 37. North America MRI Contrast Agents Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 38. North America MRI Contrast Agents Sales (Liter) by Country (2020 VS 2024 VS 2031)
Table 39. Europe MRI Contrast Agents Growth Accelerators and Market Barriers
Table 40. Europe MRI Contrast Agents Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Europe MRI Contrast Agents Sales (Liter) by Country (2020 VS 2024 VS 2031)
Table 42. Asia-Pacific MRI Contrast Agents Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 43. Asia-Pacific MRI Contrast Agents Sales (Liter) by Country (2020 VS 2024 VS 2031)
Table 44. Asia-Pacific MRI Contrast Agents Growth Accelerators and Market Barriers
Table 45. Southeast Asia MRI Contrast Agents Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Central and South America MRI Contrast Agents Investment Opportunities and Key Challenges
Table 47. Central and South America MRI Contrast Agents Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 48. Middle East and Africa MRI Contrast Agents Investment Opportunities and Key Challenges
Table 49. Middle East and Africa MRI Contrast Agents Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
Table 50. Bayer Corporation Information
Table 51. Bayer Description and Major Businesses
Table 52. Bayer Product Models, Descriptions and Specifications
Table 53. Bayer Sales (Liter), Revenue (US$ Million), Price (US$/mL) and Gross Margin (2020-2025)
Table 54. Bayer Sales Value Proportion by Product in 2024
Table 55. Bayer Sales Value Proportion by Application in 2024
Table 56. Bayer Sales Value Proportion by Geographic Area in 2024
Table 57. Bayer MRI Contrast Agents SWOT Analysis
Table 58. Bayer Recent Developments
Table 59. Guerbet Group Corporation Information
Table 60. Guerbet Group Description and Major Businesses
Table 61. Guerbet Group Product Models, Descriptions and Specifications
Table 62. Guerbet Group Sales (Liter), Revenue (US$ Million), Price (US$/mL) and Gross Margin (2020-2025)
Table 63. Guerbet Group Sales Value Proportion by Product in 2024
Table 64. Guerbet Group Sales Value Proportion by Application in 2024
Table 65. Guerbet Group Sales Value Proportion by Geographic Area in 2024
Table 66. Guerbet Group MRI Contrast Agents SWOT Analysis
Table 67. Guerbet Group Recent Developments
Table 68. Bracco Imaging Corporation Information
Table 69. Bracco Imaging Description and Major Businesses
Table 70. Bracco Imaging Product Models, Descriptions and Specifications
Table 71. Bracco Imaging Sales (Liter), Revenue (US$ Million), Price (US$/mL) and Gross Margin (2020-2025)
Table 72. Bracco Imaging Sales Value Proportion by Product in 2024
Table 73. Bracco Imaging Sales Value Proportion by Application in 2024
Table 74. Bracco Imaging Sales Value Proportion by Geographic Area in 2024
Table 75. Bracco Imaging MRI Contrast Agents SWOT Analysis
Table 76. Bracco Imaging Recent Developments
Table 77. GE Healthcare Corporation Information
Table 78. GE Healthcare Description and Major Businesses
Table 79. GE Healthcare Product Models, Descriptions and Specifications
Table 80. GE Healthcare Sales (Liter), Revenue (US$ Million), Price (US$/mL) and Gross Margin (2020-2025)
Table 81. GE Healthcare Sales Value Proportion by Product in 2024
Table 82. GE Healthcare Sales Value Proportion by Application in 2024
Table 83. GE Healthcare Sales Value Proportion by Geographic Area in 2024
Table 84. GE Healthcare MRI Contrast Agents SWOT Analysis
Table 85. GE Healthcare Recent Developments
Table 86. BeiLu Pharma Corporation Information
Table 87. BeiLu Pharma Description and Major Businesses
Table 88. BeiLu Pharma Product Models, Descriptions and Specifications
Table 89. BeiLu Pharma Sales (Liter), Revenue (US$ Million), Price (US$/mL) and Gross Margin (2020-2025)
Table 90. BeiLu Pharma Sales Value Proportion by Product in 2024
Table 91. BeiLu Pharma Sales Value Proportion by Application in 2024
Table 92. BeiLu Pharma Sales Value Proportion by Geographic Area in 2024
Table 93. BeiLu Pharma MRI Contrast Agents SWOT Analysis
Table 94. BeiLu Pharma Recent Developments
Table 95. Hengrui Medicine Corporation Information
Table 96. Hengrui Medicine Description and Major Businesses
Table 97. Hengrui Medicine Product Models, Descriptions and Specifications
Table 98. Hengrui Medicine Sales (Liter), Revenue (US$ Million), Price (US$/mL) and Gross Margin (2020-2025)
Table 99. Hengrui Medicine Recent Developments
Table 100. Key Raw Materials Distribution
Table 101. Raw Materials Key Suppliers
Table 102. Critical Raw Material Supplier Concentration (2024) & Risk Index
Table 103. Milestones in Production Technology Evolution
Table 104. Distributors List
Table 105. Market Trends and Market Evolution
Table 106. Market Drivers and Opportunities
Table 107. Market Challenges, Risks, and Restraints
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. MRI Contrast Agents Product Picture
Figure 2. Global MRI Contrast Agents Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
Figure 3. Gadobutrol Product Picture
Figure 4. Gadoterate Meglumine Product Picture
Figure 5. Gadobenate Dimeglumine Product Picture
Figure 6. Gadopentetate Dimeglumine Product Picture
Figure 7. Gadoteridol Product Picture
Figure 8. Gadodiamine Product Picture
Figure 9. Others Product Picture
Figure 10. Global MRI Contrast Agents Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
Figure 11. Hospitals
Figure 12. Clinics
Figure 13. MRI Contrast Agents Report Years Considered
Figure 14. Global MRI Contrast Agents Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global MRI Contrast Agents Revenue (2020-2031) & (US$ Million)
Figure 16. Global MRI Contrast Agents Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
Figure 17. Global MRI Contrast Agents Revenue Market Share by Region (2020-2031)
Figure 18. Global MRI Contrast Agents Sales (2020-2031) & (Liter)
Figure 19. Global MRI Contrast Agents Sales (CAGR) by Region (2020-2031) (Liter)
Figure 20. Global MRI Contrast Agents Sales Market Share by Region (2020-2031)
Figure 21. Top 5 and Top 10 Manufacturers MRI Contrast Agents Sales Volume Market Share in 2024
Figure 22. Global MRI Contrast Agents Revenue Market Share Ranking (2024)
Figure 23. Tier Distribution by Revenue Contribution (2020 VS 2024)
Figure 24. Gadobutrol Revenue Market Share by Manufacturer in 2024
Figure 25. Gadoterate Meglumine Revenue Market Share by Manufacturer in 2024
Figure 26. Gadobenate Dimeglumine Revenue Market Share by Manufacturer in 2024
Figure 27. Gadopentetate Dimeglumine Revenue Market Share by Manufacturer in 2024
Figure 28. Gadoteridol Revenue Market Share by Manufacturer in 2024
Figure 29. Gadodiamine Revenue Market Share by Manufacturer in 2024
Figure 30. Others Revenue Market Share by Manufacturer in 2024
Figure 31. Global MRI Contrast Agents Sales Market Share by Type (2020-2031)
Figure 32. Global MRI Contrast Agents Revenue Market Share by Type (2020-2031)
Figure 33. Global MRI Contrast Agents Sales Market Share by Application (2020-2031)
Figure 34. Global MRI Contrast Agents Revenue Market Share by Application (2020-2031)
Figure 35. North America MRI Contrast Agents Sales YoY (2020-2031) & (Liter)
Figure 36. North America MRI Contrast Agents Revenue YoY (2020-2031) & (US$ Million)
Figure 37. North America Top 5 Manufacturers MRI Contrast Agents Sales Revenue (US$ Million) in 2024
Figure 38. North America MRI Contrast Agents Sales Volume (Liter) by Type (2020- 2031)
Figure 39. North America MRI Contrast Agents Sales Revenue (US$ Million) by Type (2020 - 2031)
Figure 40. North America MRI Contrast Agents Sales Volume (Liter) by Application (2020-2031)
Figure 41. North America MRI Contrast Agents Sales Revenue (US$ Million) by Application (2020-2031)
Figure 42. US MRI Contrast Agents Revenue (2020-2031) & (US$ Million)
Figure 43. Canada MRI Contrast Agents Revenue (2020-2031) & (US$ Million)
Figure 44. Mexico MRI Contrast Agents Revenue (2020-2031) & (US$ Million)
Figure 45. Europe MRI Contrast Agents Sales YoY (2020-2031) & (Liter)
Figure 46. Europe MRI Contrast Agents Revenue YoY (2020-2031) & (US$ Million)
Figure 47. Europe Top 5 Manufacturers MRI Contrast Agents Sales Revenue (US$ Million) in 2024
Figure 48. Europe MRI Contrast Agents Sales Volume (Liter) by Type (2020-2031)
Figure 49. Europe MRI Contrast Agents Sales Revenue (US$ Million) by Type (2020-2031)
Figure 50. Europe MRI Contrast Agents Sales Volume (Liter) by Application (2020-2031)
Figure 51. Europe MRI Contrast Agents Sales Revenue (US$ Million) by Application (2020-2031)
Figure 52. Germany MRI Contrast Agents Revenue (2020-2031) & (US$ Million)
Figure 53. France MRI Contrast Agents Revenue (2020-2031) & (US$ Million)
Figure 54. U.K. MRI Contrast Agents Revenue (2020-2031) & (US$ Million)
Figure 55. Italy MRI Contrast Agents Revenue (2020-2031) & (US$ Million)
Figure 56. Russia MRI Contrast Agents Revenue (2020-2031) & (US$ Million)
Figure 57. Asia-Pacific MRI Contrast Agents Sales YoY (2020-2031) & (Liter)
Figure 58. Asia-Pacific MRI Contrast Agents Revenue YoY (2020-2031) & (US$ Million)
Figure 59. Asia-Pacific Top 8 Manufacturers MRI Contrast Agents Sales Revenue (US$ Million) in 2024
Figure 60. Asia-Pacific MRI Contrast Agents Sales Volume (Liter) by Type (2020- 2031)
Figure 61. Asia-Pacific MRI Contrast Agents Sales Revenue (US$ Million) by Type (2020- 2031)
Figure 62. Asia-Pacific MRI Contrast Agents Sales Volume (Liter) by Application (2020-2031)
Figure 63. Asia-Pacific MRI Contrast Agents Sales Revenue (US$ Million) by Application (2020-2031)
Figure 64. Indonesia MRI Contrast Agents Revenue (2020-2031) & (US$ Million)
Figure 65. Japan MRI Contrast Agents Revenue (2020-2031) & (US$ Million)
Figure 66. South Korea MRI Contrast Agents Revenue (2020-2031) & (US$ Million)
Figure 67. China Taiwan MRI Contrast Agents Revenue (2020-2031) & (US$ Million)
Figure 68. India MRI Contrast Agents Revenue (2020-2031) & (US$ Million)
Figure 69. Central and South America MRI Contrast Agents Sales YoY (2020-2031) & (Liter)
Figure 70. Central and South America MRI Contrast Agents Revenue YoY (2020-2031) & (US$ Million)
Figure 71. Central and South America Top 5 Manufacturers MRI Contrast Agents Sales Revenue (US$ Million) in 2024
Figure 72. Central and South America MRI Contrast Agents Sales Volume (Liter) by Type (2021-2031)
Figure 73. Central and South America MRI Contrast Agents Sales Revenue (US$ Million) by Type (2020-2031)
Figure 74. Central and South America MRI Contrast Agents Sales Volume (Liter) by Application (2020-2031)
Figure 75. Central and South America MRI Contrast Agents Sales Revenue (US$ Million) by Application (2020-2031)
Figure 76. Brazil MRI Contrast Agents Revenue (2020-2025) & (US$ Million)
Figure 77. Argentina MRI Contrast Agents Revenue (2020-2025) & (US$ Million)
Figure 78. Middle East, and Africa MRI Contrast Agents Sales YoY (2020-2031) & (Liter)
Figure 79. Middle East and Africa MRI Contrast Agents Revenue YoY (2020-2031) & (US$ Million)
Figure 80. Middle East and Africa Top 5 Manufacturers MRI Contrast Agents Sales Revenue (US$ Million) in 2024
Figure 81. Middle East and Africa MRI Contrast Agents Sales Volume (Liter) by Type (2021-2031)
Figure 82. South America MRI Contrast Agents Sales Revenue (US$ Million) by Type (2020-2031)
Figure 83. Middle East and Africa MRI Contrast Agents Sales Volume (Liter) by Application (2020-2031)
Figure 84. Middle East and Africa MRI Contrast Agents Sales Revenue (US$ Million) by Application (2020-2031)
Figure 85. GCC Countries MRI Contrast Agents Revenue (2020-2025) & (US$ Million)
Figure 86. Turkey MRI Contrast Agents Revenue (2020-2025) & (US$ Million)
Figure 87. Egypt MRI Contrast Agents Revenue (2020-2025) & (US$ Million)
Figure 88. South Africa MRI Contrast Agents Revenue (2020-2025) & (US$ Million)
Figure 89. MRI Contrast Agents Industry Chain Mapping
Figure 90. Regional MRI Contrast Agents Manufacturing Base Distribution (%)
Figure 91. Global MRI Contrast Agents Production Market Share by Region (2020-2031)
Figure 92. MRI Contrast Agents Production Process
Figure 93. Regional MRI Contrast Agents Production Cost Structure
Figure 94. Channels of Distribution (Direct Vs Distribution)
Figure 95. Bottom-up and Top-down Approaches for This Report
Figure 96. Data Triangulation
Figure 97. Key Executives Interviewed
KEY QUESTIONS ADDRESSED BY THE REPORT
What was the global market size of MRI Contrast Agents in 2025?
The global market size of MRI Contrast Agents in 2025 was 1661 Million USD.
What is the annual compound growth rate of the global MRI Contrast Agents market size from 2025 to 2031?
Which region is expected to have the highest market share?
What was the global market size of MRI Contrast Agents in 2031?
Which companies rank high in the global MRI Contrast Agents market?
Related Reports
Global MRI Contrast Agents Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global MRI Contrast Agents market size was US$ 1661 million in 2025 and is forecast to reach a readjusted size of US$ 2463 million by 2032 with a CAGR of 5.9% during the forecast period 2026-2032.
Published Date: 2026-01-05
Pages: 80
USD 4250.00
(Single User License)
Global MRI Contrast Agents Market Research Report 2026
The global MRI Contrast Agents market was valued at US$ 1661 million in 2025 and is anticipated to reach US$ 2463 million by 2032, at a CAGR of 5.9% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 116
USD 2900.00
(Single User License)
MRI Contrast Agents- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for MRI Contrast Agents was estimated to be worth US$ 1661 million in 2025 and is projected to reach US$ 2463 million, growing at a CAGR of 5.9% from 2026 to 2032.
Published Date: 2026-01-05
Pages: 94
USD 3950.00
(Single User License)
Global MRI Contrast Agents Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global MRI Contrast Agents market size was US$ 1578 million in 2024 and is forecast to a readjusted size of US$ 2339 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published Date: 2025-09-10
Pages: 77
USD 4250.00
(Single User License)
MRI Contrast Agents- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for MRI Contrast Agents was estimated to be worth US$ 1578 million in 2024 and is forecast to a readjusted size of US$ 2339 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published Date: 2025-02-07
Pages: 91
USD 3950.00
(Single User License)
Global MRI Contrast Agents Market Research Report 2025
The global market for MRI Contrast Agents was valued at US$ 1578 million in the year 2024 and is projected to reach a revised size of US$ 2339 million by 2031, growing at a CAGR of 5.9% during the forecast period.
Published Date: 2025-02-07
Pages: 80
USD 2900.00
(Single User License)
MRI Contrast Agents - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
MRI contrast agents are contrast agents used to improve the visibility of internal body structures in magnetic resonance imaging (MRI). The most commonly used compounds for contrast enhancement are gadolinium-based. Such MRI contrast agents shorten the relaxation times of nuclei within body tissues following oral or intravenous administration.
Published Date: 2024-01-18
Pages: 100
USD 3950.00
(Single User License)
Global MRI Contrast Agents Market Research Report 2024
MRI contrast agents are contrast agents used to improve the visibility of internal body structures in magnetic resonance imaging (MRI). The most commonly used compounds for contrast enhancement are gadolinium-based. Such MRI contrast agents shorten the relaxation times of nuclei within body tissues following oral or intravenous administration.
Published Date: 2024-01-03
Pages: 84
USD 2900.00
(Single User License)
Global MRI Contrast Agents Sales Market Report, Competitive Analysis and Regional Opportunities 2026-2032
The global MRI Contrast Agents market size was US$ 1661 million in 2025 and is forecast to reach a readjusted size of US$ 2463 million by 2032 with a CAGR of 5.9% during the forecast period 2026-2032.
Published: 2026-01-05
Pages: 80
USD 4250.00 (Single User License)Global MRI Contrast Agents Market Research Report 2026
The global MRI Contrast Agents market was valued at US$ 1661 million in 2025 and is anticipated to reach US$ 2463 million by 2032, at a CAGR of 5.9% from 2026 to 2032.
Published: 2026-01-05
Pages: 116
USD 2900.00 (Single User License)MRI Contrast Agents- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
The global market for MRI Contrast Agents was estimated to be worth US$ 1661 million in 2025 and is projected to reach US$ 2463 million, growing at a CAGR of 5.9% from 2026 to 2032.
Published: 2026-01-05
Pages: 94
USD 3950.00 (Single User License)Global MRI Contrast Agents Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
The global MRI Contrast Agents market size was US$ 1578 million in 2024 and is forecast to a readjusted size of US$ 2339 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published: 2025-09-10
Pages: 77
USD 4250.00 (Single User License)MRI Contrast Agents- Global Market Share and Ranking, Overall Sales and Demand Forecast 2025-2031
The global market for MRI Contrast Agents was estimated to be worth US$ 1578 million in 2024 and is forecast to a readjusted size of US$ 2339 million by 2031 with a CAGR of 5.9% during the forecast period 2025-2031.
Published: 2025-02-07
Pages: 91
USD 3950.00 (Single User License)Global MRI Contrast Agents Market Research Report 2025
The global market for MRI Contrast Agents was valued at US$ 1578 million in the year 2024 and is projected to reach a revised size of US$ 2339 million by 2031, growing at a CAGR of 5.9% during the forecast period.
Published: 2025-02-07
Pages: 80
USD 2900.00 (Single User License)MRI Contrast Agents - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
MRI contrast agents are contrast agents used to improve the visibility of internal body structures in magnetic resonance imaging (MRI). The most commonly used compounds for contrast enhancement are gadolinium-based. Such MRI contrast agents shorten the relaxation times of nuclei within body tissues following oral or intravenous administration.
Published: 2024-01-18
Pages: 100
USD 3950.00 (Single User License)Global MRI Contrast Agents Market Research Report 2024
MRI contrast agents are contrast agents used to improve the visibility of internal body structures in magnetic resonance imaging (MRI). The most commonly used compounds for contrast enhancement are gadolinium-based. Such MRI contrast agents shorten the relaxation times of nuclei within body tissues following oral or intravenous administration.
Published: 2024-01-03
Pages: 84
USD 2900.00 (Single User License)
CHOOSE LICENSE TYPE
USD 4900.00
USD 7350.00
USD 9800.00
Add to Cart
Buy Now
HAVE A QUESTION?
General Email:
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now